Skip to main content
. 2022 Oct 17;20(5):408–423. doi: 10.1089/hs.2022.0014

Figure 1.

Figure 1.

Overview of in vivo (A) administration routes of nanoparticles and (B) biodistribution strategies of nanoparticles (ie, passive and targeted delivery) using coatings. Note that passive delivery strategies demonstrated here rely on stealth coatings to bypass in vivo clearance mechanisms to increase circulation time. Abbreviation: NP, nanoparticle.